Alpha6-containing nicotinic acetylcholine receptor (α6* nAChR)

Alpha6-containing nicotinic acetylcholine receptors (α6* nAChRs) are a specialized subtype of ligand-gated ion channels primarily expressed in the midbrain dopaminergic system, including the substantia nigra and ventral tegmental area. These receptors play a critical role in modulating dopamine release in the striatum and nucleus accumbens, making them central to the brain's reward and motor control pathways. They typically assemble as heteromers, often incorporating β2, β3, and sometimes α4 subunits. Due to their restricted expression on dopaminergic neurons, they are considered high-value therapeutic targets for Parkinson's disease, where they may help maintain dopaminergic tone, and for nicotine and alcohol addiction, where they mediate the reinforcing effects of these substances. Pharmacological development has been historically hindered by the difficulty of expressing these receptors in vitro and a lack of selective small-molecule ligands, though α-conotoxins serve as important research tools. Targeting these receptors offers a potential pathway for treating addiction by attenuating the rewarding properties of drugs without the widespread side effects associated with more common nicotinic subtypes.

Other names

CHRNA6Alpha6 nicotinic receptor subunitnAChR alpha6Cholinergic receptor nicotinic alpha 6 subunitNeuronal acetylcholine receptor subunit alpha-6Alpha6* nicotinic acetylcholine receptor

Agonism or partial agonism at α6-containing receptors stimulates the release of dopamine in the mesolimbic and nigrostriatal pathways, while antagonism or blockade of these receptors inhibits the rewarding and reinforcing effects of addictive substances like nicotine and alcohol.